PRIA Logo™
119-hres-685119th CongressWALLET

Expressing support for testing for antiphospholipid syndrome (APS) as a standard part of prenatal screening, and for other purposes.

Sponsored By: Representative Cammack, Kat [R-FL-3]

Introduced

Summary

Make antiphospholipid syndrome testing a standard part of prenatal screening. This resolution would push for routine blood testing for antiphospholipid syndrome and call on medical guideline bodies to change their recommendations so testing happens earlier in pregnancy.

Show full summary
  • Pregnant people: Would increase early detection of APS, which is linked to about 15% of recurrent pregnancy losses. APS can be detected by a blood test and is often treatable with blood thinners.
  • Families: Could reduce miscarriages, stillbirths, and the grief those losses cause by finding and treating APS sooner.
  • Medical guideline bodies: Would be urged to replace current guidance that limits APS testing to cases after an unexplained fetal loss after 10 weeks or after three or more unexplained embryonic losses.

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Free to download

Bill Overview

Analyzed Economic Effects

1 provisions identified: 1 benefits, 0 costs, 0 mixed.

More prenatal testing for antiphospholipid syndrome

If adopted, this resolution would support routine prenatal testing for antiphospholipid syndrome (APS). It would call on medical societies and guideline bodies to add APS testing to standard prenatal screening. The resolution is non-binding and would not itself change federal law or insurance rules. It notes APS raises the risk of blood clots and pregnancy loss. It also says APS may cause about 15 percent of recurrent pregnancy losses. If guidelines and insurers follow, pregnant people could get earlier diagnosis and blood-thinner treatment.

Sponsors & CoSponsors

Sponsor

Cammack, Kat [R-FL-3]

FL • R

Cosponsors

  • Rep. Kamlager-Dove, Sydney [D-CA-37]

    CA • D

    Sponsored 9/9/2025

  • Rep. Kim, Young [R-CA-40]

    CA • R

    Sponsored 9/9/2025

  • Rep. Pettersen, Brittany [D-CO-7]

    CO • D

    Sponsored 9/9/2025

  • Rep. Hinson, Ashley [R-IA-2]

    IA • R

    Sponsored 9/9/2025

  • Rep. Adams, Alma S. [D-NC-12]

    NC • D

    Sponsored 9/9/2025

  • Rep. Cherfilus-McCormick, Sheila [D-FL-20]

    FL • D

    Sponsored 9/9/2025

  • Rep. Landsman, Greg [D-OH-1]

    OH • D

    Sponsored 9/9/2025

  • Rep. Luna, Anna Paulina [R-FL-13]

    FL • R

    Sponsored 9/26/2025

Roll Call Votes

No roll call votes available for this bill.

View on Congress.gov
Back to Legislation